RIN-25

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameRIN-25
Drug Alias NameRIN-42 derivative (National Institutes of Health)Indolicidin derivative (National Institutes of Health)RIN-25
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionHIV integrase inhibitors
TargetsHIV integrase
Therapy Area/IndicationsRetroviridae Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Health
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of Health
Active IndicationsN/A
Inactive IndicationsRetroviridae Infections

Other Information

ATC CodeN/A
Related LinksN/A